ATE402932T1 - Neue tetracyclische tetrahydrofuranderivate - Google Patents
Neue tetracyclische tetrahydrofuranderivateInfo
- Publication number
- ATE402932T1 ATE402932T1 AT05752829T AT05752829T ATE402932T1 AT E402932 T1 ATE402932 T1 AT E402932T1 AT 05752829 T AT05752829 T AT 05752829T AT 05752829 T AT05752829 T AT 05752829T AT E402932 T1 ATE402932 T1 AT E402932T1
- Authority
- AT
- Austria
- Prior art keywords
- tetrahydrofuran derivatives
- tetracyclic tetrahydrofuran
- new tetracyclic
- new
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Child & Adolescent Psychology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP2004051105 | 2004-06-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE402932T1 true ATE402932T1 (de) | 2008-08-15 |
Family
ID=34957878
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT05752829T ATE402932T1 (de) | 2004-06-14 | 2005-06-13 | Neue tetracyclische tetrahydrofuranderivate |
Country Status (15)
Country | Link |
---|---|
US (1) | US20070197525A1 (de) |
EP (1) | EP1761514B1 (de) |
JP (1) | JP2008502649A (de) |
CN (1) | CN1968942B (de) |
AR (1) | AR049512A1 (de) |
AT (1) | ATE402932T1 (de) |
AU (1) | AU2005251948A1 (de) |
CA (1) | CA2567847A1 (de) |
DE (1) | DE602005008596D1 (de) |
DK (1) | DK1761514T3 (de) |
ES (1) | ES2311228T3 (de) |
PL (1) | PL1761514T3 (de) |
PT (1) | PT1761514E (de) |
TW (1) | TW200612899A (de) |
WO (1) | WO2005121113A1 (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2007014857A (es) * | 2005-05-26 | 2008-02-14 | Janssen Pharmaceutica Nv | Derivados de tetrahidrofurano, pirrolidina y tetrahidrotiofeno tetraciclicos, sustituidos, novedosos y su uso como un medicamento. |
EP2727585A1 (de) | 2006-05-16 | 2014-05-07 | Takeda Pharmaceutical Company Limited | In-vivo Screening-Methode |
US20100266504A1 (en) | 2007-11-15 | 2010-10-21 | Takahiro Matsumoto | Condensed pyridine derivative and use thereof |
AU2009335709A1 (en) | 2008-12-19 | 2011-07-14 | Supernus Pharmaceuticals, Inc. | Method of treatment of aggression |
EP3572074B1 (de) | 2010-03-31 | 2021-01-06 | Supernus Pharmaceuticals, Inc. | Stabilisierte formulierungen aus molindone |
WO2013018899A1 (ja) * | 2011-08-03 | 2013-02-07 | 協和発酵キリン株式会社 | ジベンゾオキセピン誘導体 |
WO2013189920A1 (en) | 2012-06-19 | 2013-12-27 | Ucb Pharma S.A. | New compound based on cinchona alkaloïds for use in asymmetric michael addition |
EP3733204A4 (de) | 2017-12-27 | 2021-09-15 | Takeda Pharmaceutical Company Limited | Therapeutikum für belastungsinkontinenz und stuhlinkontinenz |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3350405A (en) * | 1964-10-16 | 1967-10-31 | Sterling Drug Inc | Amino-lower-alkoxy-dibenzo [a, d] cyclohepten-5-ones and 10, 11-dihydro derivatives thereof |
US3507920A (en) * | 1964-10-16 | 1970-04-21 | Sterling Drug Inc | Hydroxydibenzo(a,d)cyclohepten-5-ones and esters and ethers thereof |
US3565956A (en) * | 1964-10-16 | 1971-02-23 | Sterling Drug Inc | Amino-lower-alkoxy-5-alkylidene-dibenzo(a,d)cycloheptenes |
US3562331A (en) * | 1964-10-16 | 1971-02-09 | Sterling Drug Inc | Amino-lower-alkoxy-dibenzo(a,d)cycloheptene-5-carbinols |
US3812119A (en) * | 1969-11-21 | 1974-05-21 | Ciba Geigy Corp | Dibenzocycloheptenes |
US6057441A (en) * | 1996-04-12 | 2000-05-02 | Janssen Pharmaceutica, N.V. | Substituted tetracyclic tetrahydrofuran derivatives |
UA52778C2 (uk) * | 1997-10-10 | 2003-01-15 | Янссен Фармацевтика Н.В. | Галогенозаміщені тетрациклічні похідні тетрагідрофурану, спосіб їх отримання та композиція на їх основі |
KR20050044329A (ko) * | 2001-12-07 | 2005-05-12 | 얀센 파마슈티카 엔.브이. | 트랜스-융합된3,3a,8,12b-테트라히드로-2H-디벤조[3,4:6,7]시클로헵타[1,2-b]푸란 유도체의 제조 |
-
2005
- 2005-06-13 AU AU2005251948A patent/AU2005251948A1/en not_active Abandoned
- 2005-06-13 PL PL05752829T patent/PL1761514T3/pl unknown
- 2005-06-13 US US11/570,433 patent/US20070197525A1/en not_active Abandoned
- 2005-06-13 WO PCT/EP2005/052706 patent/WO2005121113A1/en active IP Right Grant
- 2005-06-13 PT PT05752829T patent/PT1761514E/pt unknown
- 2005-06-13 DK DK05752829T patent/DK1761514T3/da active
- 2005-06-13 DE DE602005008596T patent/DE602005008596D1/de active Active
- 2005-06-13 EP EP05752829A patent/EP1761514B1/de active Active
- 2005-06-13 JP JP2007515942A patent/JP2008502649A/ja active Pending
- 2005-06-13 TW TW094119426A patent/TW200612899A/zh unknown
- 2005-06-13 CN CN2005800194190A patent/CN1968942B/zh not_active Expired - Fee Related
- 2005-06-13 CA CA002567847A patent/CA2567847A1/en not_active Abandoned
- 2005-06-13 AT AT05752829T patent/ATE402932T1/de active
- 2005-06-13 ES ES05752829T patent/ES2311228T3/es active Active
- 2005-06-13 AR ARP050102402A patent/AR049512A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1761514A1 (de) | 2007-03-14 |
US20070197525A1 (en) | 2007-08-23 |
WO2005121113A1 (en) | 2005-12-22 |
PT1761514E (pt) | 2008-10-28 |
PL1761514T3 (pl) | 2009-01-30 |
DE602005008596D1 (de) | 2008-09-11 |
CA2567847A1 (en) | 2005-12-22 |
DK1761514T3 (da) | 2008-12-01 |
EP1761514B1 (de) | 2008-07-30 |
AR049512A1 (es) | 2006-08-09 |
TW200612899A (en) | 2006-05-01 |
CN1968942B (zh) | 2011-06-15 |
CN1968942A (zh) | 2007-05-23 |
ES2311228T3 (es) | 2009-02-01 |
JP2008502649A (ja) | 2008-01-31 |
AU2005251948A1 (en) | 2005-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE387440T1 (de) | Neue 4-benzylidenpiperidinderivate | |
IS8578A (is) | 3- karbamoýl - 2- pýridón afleiður | |
DK1761541T3 (da) | Pyrrazolo-pyrimidin-derivater | |
ATE394399T1 (de) | Tetrahydropyridoindolderivate | |
ATE540935T1 (de) | Chinazolinderivate | |
ATE413874T1 (de) | Neue thiophen-derivate als sphingosin-1-phosphat- 1-rezeptorantagonisten | |
ATE523195T1 (de) | Neue thiophen-derivate als sphingosin-1-phosphat- 1-rezeptorantagonisten | |
DE602005027445D1 (de) | Neue zusammensetzungen mit chinolin-verbindungen | |
DE602007003343D1 (de) | Neue mikrobiozide | |
ATE417830T1 (de) | Sulfonylbenzimidazolderivate | |
ATE553079T1 (de) | Heteroarylphenylharnstoffderivat | |
ATE415385T1 (de) | Hexafluorisopropanolsubstituierte etherderivate | |
ATE425167T1 (de) | Neue pyridothienopyrimidinderivate | |
ATE466857T1 (de) | Neue piperidin-antibiotika | |
DE602005023145D1 (de) | Neue androgene | |
DE602005007714D1 (de) | Neue quaternisierte chinuclidinester | |
ATE430142T1 (de) | Phenylpiperazin-methanon-derivate | |
ATE402932T1 (de) | Neue tetracyclische tetrahydrofuranderivate | |
ATE404542T1 (de) | 4-phenylpyrimidin-2-carbonitrilderivate | |
DE602005018177D1 (de) | Drehzerstäubungskopf-lackiervorrichtung | |
ATE365731T1 (de) | 4-amino-5-cyanopyrimidinderivate | |
ATE445604T1 (de) | Neue 2,6-diaminopyridin-3-on-derivate | |
SE0400898L (sv) | Flytkonstruktion | |
ATE524461T1 (de) | Neue substituierte piperidylpropanthiole | |
ATE369347T1 (de) | Trimere makrocyclisch substituierte halogen- benzolderivate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1761514 Country of ref document: EP |